

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 120mg | 360 pills | A$1.80 | A$808.77 A$647.02 Best Price | |
| 120mg | 180 pills | A$1.86 | A$419.25 A$335.40 | |
| 120mg | 120 pills | A$1.97 | A$294.82 A$235.86 | |
| 120mg | 90 pills | A$2.03 | A$229.90 A$183.92 | |
| 120mg | 60 pills | A$2.23 | A$167.68 A$134.15 | |
| 120mg | 30 pills | A$2.51 | A$94.65 A$75.72 | |
| 240mg | 360 pills | A$2.10 | A$944.03 A$755.22 Popular | |
| 240mg | 180 pills | A$2.16 | A$486.88 A$389.50 | |
| 240mg | 120 pills | A$2.25 | A$338.10 A$270.48 | |
| 240mg | 90 pills | A$2.40 | A$270.48 A$216.38 | |
| 240mg | 60 pills | A$2.60 | A$194.73 A$155.79 | |
| 240mg | 30 pills | A$2.88 | A$108.17 A$86.54 |
Calan SR is a brand name used for verapamil sustained-release tablets, a medicine in the calcium channel blocker family. It is designed to be taken regularly to help manage conditions related to heart and blood vessel function. In Australia, Calan SR may require a prescription depending on local rules, and it should be taken under the supervision of a healthcare professional. Always read the official patient information leaflet that comes with the medicine for the exact instructions that apply to you.
Verapamil works by relaxing the smooth muscle in the walls of arteries and by slowing the electrical signals in the heart. This combination reduces the heart’s workload and lowers blood pressure, while also easing chest pain in some people with heart disease. The sustained-release formulation means the medicine is released gradually over time to maintain a steadier level in the blood. This helps with ongoing control rather than rapid changes in effect.
The exact role of Calan SR depends on your specific health needs and other medicines you may be taking. It is not a rapid-acting treatment for acute symptoms, and it should not be used to treat sudden chest pain without other prescribed medications and medical guidance. If you have questions about whether Calan SR is right for you, check the official leaflet and talk with your doctor or pharmacist.
As with all medicines, benefits and risks are weighed by your healthcare professional. If you have a known allergy to verapamil or any ingredient in the tablet, or you have certain heart conditions, your clinician will determine whether Calan SR is appropriate. For personalised advice, always rely on your prescribing clinician and the information provided with the product.
Calan SR is commonly used to treat high blood pressure (hypertension) to reduce the risk of complications such as stroke or heart attack. It may be prescribed on its own or together with other blood pressure-lowering medicines as part of a comprehensive treatment plan. The goal is to lower blood pressure gradually to safer levels while minimising side effects.
Another main use is to prevent chest pain (angina) in people with coronary artery disease. By easing the heart’s workload and improving blood flow to the heart muscle, Calan SR can help reduce the frequency and severity of angina episodes. In some individuals, improved exercise tolerance may accompany these effects as symptoms become more manageable during activity.
In certain circumstances, Calan SR may be used to help manage specific heart rhythm problems under careful medical supervision. The medicine can influence how electrical impulses travel through the heart, which may help regulate a heart rate in some tachycardia conditions. The suitability for this use depends on the individual’s heart rhythm and other medications being taken.
This information is not a substitute for medical advice. The exact indications for Calan SR will be decided by a clinician based on your health history and current treatment plan. If you are unsure whether this medicine is intended for your condition, ask a healthcare professional for clarification and rely on their guidance.
Verapamil blocks calcium entry into heart and vascular smooth muscle cells. This action reduces the strength of heart contractions and dilates arteries, which lowers blood pressure and can lessen the heart’s workload. By reducing afterload and improving blood flow, the heart requires less oxygen during activity, which can help relieve angina symptoms in some patients.
In addition, verapamil slows conduction through the heart’s electrical pathways. This can help control certain abnormal heart rhythms by reducing excessive electrical activity that can cause rapid heart rates. The exact effect on rhythm depends on the person’s condition and how the medicine interacts with other heart medicines.
The sustained-release formulation is designed to provide a steady release of verapamil over time, helping maintain stable blood levels. This approach aims to reduce large fluctuations that might lead to side effects or diminished effectiveness. You may notice gradual, ongoing improvements rather than immediate changes after starting Calan SR.
Because individual responses vary, it may take time to notice full benefits in blood pressure control or angina prevention. If there is no improvement after a reasonable period, or if symptoms worsen, consult a healthcare professional for reassessment and possible adjustments to the treatment plan. This is an important step to ensure safety and effectiveness in your care.
Take Calan SR exactly as prescribed by your healthcare professional. Do not change the dose or frequency without medical guidance. The tablet should be swallowed whole with a full glass of water; do not crush, chew, or break the sustained-release tablet, as altering the release mechanism can change how the medicine works and may increase side effects.
You can take Calan SR with or without food. Some people find taking it at the same time each day helps with adherence, while others prefer a meal to minimise stomach upset. The key is consistency and following the schedule provided by your clinician. If you have trouble remembering doses, discuss a plan with your pharmacist or doctor.
If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. If you are near the time for your next dose, skip the missed one and resume your regular schedule. Do not take a double dose to make up for a missed one. If you are unsure what to do, contact a pharmacist for guidance.
Tell your clinician about all medicines you take, including non-prescription medicines and herbal supplements, as interactions can occur. This information helps ensure safe use of Calan SR in combination with other therapies. Always refer to the official leaflet for detailed storage and safety instructions specific to your product.
Do not take Calan SR if you have a known allergy to verapamil or any other component of the tablet. An allergic reaction can be serious and may include skin rashes, swelling, or breathing difficulties. If you notice any signs of an allergic reaction, seek medical advice promptly.
Calan SR may not be suitable for people with certain heart conditions, such as very slow heart rate, complete heart block, or certain conduction disorders, unless a pacemaker is present or advised by a clinician. It is also generally avoided in people with severe low blood pressure or heart failure with reduced pumping efficiency, unless specifically directed by a doctor.
Pregnancy and breastfeeding require careful consideration. If you are pregnant, planning to become pregnant, or currently breastfeeding, discuss potential risks and benefits with your clinician. They can help determine whether Calan SR remains appropriate during this period or if an alternative treatment would be safer.
Calan SR may interact with other medicines used for heart conditions, as well as certain antibiotics, antifungals, or other therapies. Inform your clinician about all medicines you take to minimise the risk of adverse interactions. If your health status changes, or you start a new medication, consult a healthcare professional for updated guidance.
Before starting Calan SR, inform your doctor about your medical history, including any heart problems, liver or kidney disease, low blood pressure, or recent heart surgery. This information helps determine whether Calan SR is appropriate for you and whether a dose adjustment is needed.
Common side effects such as dizziness, lightheadedness, or fatigue can occur, especially when beginning treatment or increasing the dose. Do not drive or operate heavy machinery if you feel unusually unsteady, and take precautions when standing up to reduce the risk of fainting. If these symptoms persist, discuss them with your clinician.
Verapamil can interact with other medicines and some herbal products. Always inform your clinician about all substances you are taking, including vitamins and supplements. Grapefruit products may interact with verapamil in some individuals; your clinician can advise whether to avoid them. Alcohol consumption may also affect blood pressure and heart function, so moderation or avoidance can be advised depending on your situation.
If you notice swelling of the legs or ankles, rapid weight gain, chest pain, irregular heartbeat, or shortness of breath, seek medical attention as directed by your clinician. These could signal a need for medical review or urgent assessment. For liver-related symptoms such as jaundice or dark urine, contact a healthcare professional promptly, as instructed in the official leaflet.
There are additional precautions for people undergoing surgical procedures or anesthesia; always inform your health team that you are taking Calan SR. This helps ensure safe management of medications and anaesthetic agents during procedures. If you have any concerns about these scenarios, your doctor or pharmacist can provide personalised guidance.
Like all medicines, Calan SR can cause side effects, though not everyone experiences them. Common, milder effects may include constipation, dizziness, flushing, or mild nausea. These symptoms can sometimes improve with time as your body adjusts to the medicine, but you should discuss ongoing issues with your clinician to determine whether any change in therapy is needed.
More serious side effects are less common but require prompt medical attention. Seek help if you develop severe allergic reactions (such as swelling of the face or lips, wheezing, or severe rash), chest pain, a very slow heart rate, fainting, swelling of legs or feet, or a significant irregular heartbeat. These could indicate a need for urgent evaluation or adjustment of treatment.
Very rare or unusual side effects may occur. If you notice any unusual or persistent symptoms after starting Calan SR, contact your healthcare professional for assessment. This information provides general guidance; your clinician can offer personalised advice based on your health status and medication profile.
If you experience signs of liver problems—such as persistent yellowing of the skin or eyes, dark urine, pale stools, or persistent abdominal pain—contact a clinician promptly. Do not ignore persistent or worsening symptoms, as early management can be important for safety. Always refer to the official leaflet for a full list of potential side effects and reporting instructions.
In the event of any suspected serious side effect, seek advice from a healthcare professional or emergency services as appropriate. This page provides general information and does not replace professional medical assessment or urgent care when required.
Calan SR can interact with a range of medicines, which may affect heart rate, blood pressure, or how well other therapies work. It is important to tell your doctor about all medicines you take, including non-prescription drugs, vitamins, and herbal supplements. Your clinician can assess potential interactions and adjust your plan if needed.
Some medicines that commonly interact with verapamil include other medicines that slow the heart or lower blood pressure, as well as certain antibiotics, antifungal drugs, or medicines that affect the rhythms of the heart. The way these interactions manifest can vary between individuals, so personalised advice from your clinician is essential. Do not start a new medicine without discussing it with your doctor or pharmacist.
Grapefruit and grapefruit juice can alter the level of verapamil in the blood, which may increase the risk of side effects for some people. Ask your clinician whether you should limit or avoid grapefruit products while taking Calan SR. It is also advisable to discuss any alcohol use, as it can interact with blood pressure management in some cases.
If you are preparing for surgery or an invasive procedure, inform your healthcare team that you are taking Calan SR, as some anaesthetic agents or other perioperative drugs can interact with calcium channel blockers. Prompt communication helps reduce risks during care. If you suspect a potential interaction, contact a pharmacist or clinician for guidance.
Because interactions can vary by individual, check the official leaflet for a comprehensive list and seek professional advice before making changes to your medication regimen. This information is intended to support, not replace, professional assessment.
In pregnancy, the decision to use verapamil should be made after careful consideration of potential benefits and risks. Your clinician will assess whether Calan SR is appropriate during pregnancy based on your health needs and alternatives. Do not start or stop treatment without medical advice during pregnancy.
Verapamil can pass into breast milk in small amounts. If you are breastfeeding or planning to breastfeed, discuss with your clinician whether continuing Calan SR is appropriate or whether an alternative approach would be safer for the baby. Do not change your treatment plan without professional guidance.
If you become pregnant while taking Calan SR, contact your clinician promptly to review your treatment. Do not rely on self-guided decisions regarding safety in pregnancy or lactation. The clinician can help determine the best course of action for both mother and child.
These considerations are individualized. For precise information, consult the official leaflet and your health care provider to understand the risks and benefits in your specific situation. Medication decisions during pregnancy or breastfeeding require professional supervision and personalised planning.
Calan SR is a prescription medicine in many settings, and your health professional can tailor information to your situation. The following questions address common concerns that patients may have when starting or continuing therapy. For any personal health decisions, rely on your clinician’s advice.
Time to effects can vary depending on the reason for use, your baseline health, and other medicines you take. You may notice gradual improvements over days to weeks in blood pressure and angina-related symptoms, rather than immediate changes. If there is no noticeable improvement after an appropriate period, consult your clinician to review the plan.
Missed doses should be handled according to your instructions; if you miss a dose, do not double up. Speak with your pharmacist or doctor if you are unsure about how to proceed. Do not take two doses at once to compensate for a forgotten tablet without professional advice.
When combining Calan SR with other heart medicines or supplements, your clinician will consider potential interactions. Do not start, stop, or change other medications without consulting them, and promptly report any new medicines or supplements you intend to use.
Response: The time to noticeable benefit can vary, but many people begin to feel improvements in blood pressure or chest pain control over days to weeks. Some effects may be evident sooner, while others require longer treatment and dose optimization under supervision. For individual timelines, rely on your clinician’s guidance and monitoring plan.
Response: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double up to catch up. If you are uncertain about what to do, contact a pharmacist for advice. Do not alter your schedule based on guesswork.
Response: Calan SR is often used with other therapies for blood pressure or heart conditions, but combining medicines can change how they work and may increase the risk of side effects. A clinician will review your full medicine list to assess compatibility and adjust treatment if needed.
Response: Alcohol can interact with blood pressure medications in some people, either increasing dizziness or affecting heart rate. It is best to discuss alcohol use with your clinician, who can provide personalised advice based on your treatment plan.
Response: The safety of Calan SR in pregnancy and breastfeeding depends on the individual case. A clinician will evaluate potential benefits and risks before continuing or adjusting treatment. Do not make changes without professional guidance.
Response: Dizziness or lightheadedness can occur, particularly after starting treatment or adjusting the dose. If you experience these effects, you should avoid driving or operating heavy machinery until you know how the medicine affects you. Consult your clinician if concerns persist.
Response: Stopping calcium channel blockers abruptly can sometimes worsen symptoms or provoke rebound effects. Do not stop treatment without discussing with your clinician, who can guide a safe plan for tapering if needed.
Response: If you experience new or severe chest pain, shortness of breath, fainting, or other signs of a heart problem, seek urgent medical help or contact your healthcare professional promptly. Calan SR is not intended for immediate relief of acute symptoms.
Response: Some non-prescription medicines and supplements can interact with verapamil. Always inform your clinician about any non-prescription products you are taking and check with a pharmacist before starting anything new.
Response: Grapefruit products can alter how verapamil is processed in the body for some people, which may affect effectiveness and safety. Your clinician can advise whether to limit or avoid grapefruit in your specific case.
Response: Store at room temperature in the original packaging or container, away from moisture and heat. Keep it out of reach of children. Do not use tablets after the expiry date. If you have questions about storage, ask your pharmacist.
Information on Calan SR is drawn from standard pharmaceutical guidance, the official patient information leaflet for verapamil SR, and general clinical practice guidelines used in Australia. For personalised advice, rely on your prescribing clinician and the product’s official documentation.
If you need more detail, consult the official leaflets provided with the medication, your pharmacist, or your doctor. They can offer country-specific guidance, dosing considerations, and monitoring plans tailored to your health needs.
Updated patient information, safety notices, and interaction checks should always be discussed with a healthcare professional, who can adapt recommendations to your medical history and concurrent therapies.
14–21 days. Free from A$279.23 .
5–9 days. A$41.88
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
